INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• The FDA's Remote Regulatory Assessments: The Future Of Inspections

  Remote Regulatory Assessments (RRAs) provide distinct advantages over traditional inspections, such as increased efficiency, reduced travel costs, and enhanced global oversight capabilities.

• 5 Key Considerations For Choosing The Right ERP

  Selecting an Enterprise Resource Planning (ERP) system is a pivotal decision for life sciences organizations, influencing regulatory compliance, operational efficiency, and long-term growth.

• Choosing RTSM? Evaluate The Team Running It, Not Just The Software

  High-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.

• Clinical Data Studio: A Single Data Review Platform Fostering Unification Across Groups

  This end-to-end digital review platform can assist both your risk management team and data management team, improving speed and facilitating database lock times.

• The Future Of Clinical Trials: AI, Real-Time Data, And FDA Innovation

  9/30/2026

  How does building trial protocols into health records lets key safety and efficacy signals reach sponsors and regulators in days, cutting manual data entry and speeding decisions.

• A Fair, Ethical Framework For Participant Payments In Clinical Trials

  3/24/2025

  Participant payments in clinical trials have long been fraught with inconsistency, raising questions about the role of IRBs, tax implications, and fair reimbursement structures.

• How Strategic LQPPV Outsourcing Future-Proofs PV Compliance In The AI Era

  8/8/2025

  As health authorities seek standardization across global processes and strong AI governance, working with an experienced PV partner will help minimize the burden of oversight and ensure compliance.

• Omics-Driven Immune Challenge Design: What Early Human Data Tells Us

  10/31/2026

  Transcriptomic and proteomic profiling of controlled human immune challenges shows which pathways, compartments, and time windows a model engages, helping match challenge choice to a drug's mechanism.

• A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data

  2/25/2025

  Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.